The developmental transcriptome of the human brain: Implications for neurodevelopmental disorders

Current Opinion in Neurology

Volumn 27, Issue 2, 2014, Pages 149-156

  Tebbenkamp, Andrew T N ^a   Willsey, A Jeremy ^a,b   State, Matthew W ^b   Šestan, Nenad ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

autism spectrum disorder; gene co expression analysis; genetics; psychiatric and neurologic disorders; schizophrenia; Williams syndrome

Indexed keywords

TRANSCRIPTOME; UNTRANSLATED RNA;

AUTISM; FETUS DEVELOPMENT; FRONTAL CORTEX; GENE EXPRESSION; GENE MUTATION; HUMAN; NERVE CELL; NERVE CELL DIFFERENTIATION; NEUROLOGIC DISEASE; PATHOGENESIS; REVIEW; SCHIZOPHRENIA; SOMATOSENSORY CORTEX; WILLIAMS BEUREN SYNDROME;

BRAIN; BRAIN DISEASES; CHILD DEVELOPMENT DISORDERS, PERVASIVE; DEVELOPMENTAL DISABILITIES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; SCHIZOPHRENIA; TRANSCRIPTOME; WILLIAMS SYNDROME;

EID: 84896393703     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0000000000000069     Document Type: Review

References (50)

1. Johnson MB, Kawasawa YI, Mason CE, et al. Functional and evolutionary insights into human brain development through global transcriptome analysis. Neuron 2009; 62:494-509.
2. Somel M, Franz H, Yan Z, et al. Transcriptional neoteny in the human brain. Proc Natl Acad Sci USA 2009; 106:5743-5748.
3. Ip BK, Wappler I, Peters H, et al. Investigating gradients of gene expression involved in early human cortical development. J Anat 2010; 217:300-311.
4. Colantuoni C, Lipska BK, Ye T, et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 2011; 4478:519-523.
5. Kang HJ, Kawasawa YI, Cheng F, et al. Spatio-temporal transcriptome of the human brain. Nature 2011; 478:483-489.
6. Lambert N, Lambot MA, Bilheu A, et al. Genes expressed in specific areas of the human fetal cerebral cortex display distinct patterns of evolution. PLoS ONE 2011; 6:17753.
7. Hawrylycz MJ, Lein ES, Guillozet-Bongaarts AL, et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 2012; 489:391-399.
8. Mazin P, Xiong J, Liu X, et al. Widespread splicing changes in human brain development and aging. Mol Syst Biol 2013; 9:633.
9. Pletikos M, Sousa AM, Sedmak G, et al. Temporal specification and bilaterality of human neocortical topographic gene expression. Neuron 2014; 81:321-332.
10. Iossifov I, Ronemus M, Levy D, et al. De novo gene disruptions in children on the autistic spectrum. Neuron 2012; 74:285-299.
11. Kong A, Frigge ML, Masson G, et al. Rate of de novo mutations and the importance of father's age to disease risk. Nature 2012; 488:471-475.
12. Neale BM, Kou Y, Liu L, et al. Patterns and rates of exonicde novo mutations in autism spectrum disorders. Nature 2012; 485:242-245.
13. Sanders SJ, Ercan-Sencicek AG, Hus V, et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 2011; 70:863-885.
14. O'Roak BJ, Vives L, Girirajan S, et al. Sporadic autism exomes reveal a highly interconnected protein networkof de novo mutations. Nature 2012; 485:246-250.
15. Sanders SJ, Murtha MT, Gupta AR, et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012; 485:237-241.
16. State MW, Sestan N. Neuroscience. The emerging biology of autism spectrum disorders. Science 2012; 337:1301-1303.
17. Voineagu I, Wang X, Johnston P, et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011; 474:380-384.
18. Martin CL, Duvall JA, Ilkin Y, et al. Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism. Am J Med Genet B Neuropsychiatr Genet 2007; 144B:869-876.
19. Peles E, Nativ M, Lustig M, et al. Identification of a novel contactin-associated transmembrane receptor with multiple domains implicated in protein-protein interactions. EMBO J 1997; 16:978-988.
20. Chow ML, Pramparo T, Winn ME, et al. Age-dependent brain gene expression and copy number anomalies in autism suggest distinct pathological processes at young versus mature ages. PLoS Genet 2012; 8:e1002592.
21. Kwan KY, Lam MM, Johnson MB, et al. Species-dependent posttranscrip-tional regulation of NOS1 by FMRP in the developing cerebral cortex. Cell 2012; 149:899-911.
22. Dolmetsch R, Geschwind DH. The human brain in a dish: the promise of iPSC-derived neurons. Cell 2011; 145:831-834.
23. Griesi-Oliveira K, Sunaga DY, Alvizi L, et al. Stem cells as a good tool to investigate dysregulated biological systems in autism spectrum disorders. Autism Res 2013; 6:354-361.
24. Smith RM, Sadee W. Synaptic signaling and aberrant RNA splicing in autism spectrum disorders. Front Synaptic Neurosci 2011; 3:1.
25. Helbig I, Mefford HC, Sharp AJ, et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet 2009; 41:160-162.
26. Weiss LA, Shen Y, Korn JM, et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 2008; 358:667-675.
27. Glessner JT, Wang K, Cai G, et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 2009; 459:569-573.
28. Pinto D, Pagnamenta AT, Klei L, et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010; 466:368-372.
29. Itsara A, Wu H, Smith JD, et al. De novo rates and selection of large copy number variation. Genome Res 2010; 20:1469-1481.
30. Marshall CR, Noor A, Vincent JB, et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 2008; 82:477-488.
31. Szatmari P, Paterson AD, Zwaigenbaum L, et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 2007; 39:319-328.
32. Luo R, Sanders SJ, Tian Y, et al. Genome-wide transcriptome profiling reveals the functional impact of rare de novo and recurrent CNVs in autism spectrum disorders. Am J Hum Genet 2012; 91:38-55.
33. Ben-David E, Shifman S. Combined analysis of exome sequencing points toward a major role for transcription regulation during brain development in autism. Mol Psychiatry 2013; 18:1054-1056.
34. Willsey AJ, Sanders SJ, Li M, et al. Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell 2013; 155:997-1007.
35. Gulsuner S, Walsh T, Watts AC, et al. Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell 2013; 154:518-529.
36. Parikshak NN, Luo R, Zhang A, et al. Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell 2013; 155:1008-1021.
37. Mulle JG, Pulver AE, McGrath JA, et al. Reciprocal duplication of the Williams-Beuren syndrome deletion on chromosome 7q11.23 is associated with schizophrenia. Biol Psychiatry 2014; 75:371-377.
38. Antonell A, Vilardell M, Perez Jurado LA. Transcriptome profile in Williams-Beuren syndrome lymphoblast cells reveals gene pathways implicated in glucose intolerance and visuospatial construction deficits. Hum Genet 2010; 128:27-37.
39. Henrichsen CN, Csardi G, Zabot MT, et al. Using transcription modules to identify expression clusters perturbed in Williams-Beuren syndrome. PLoS Comput Biol 2011; 7: e1001054.
40. Drummond JB, Simmons M, Haroutunian V, Meador-Woodruff JH. Upregula-tion of cornichon transcripts in the dorsolateral prefrontal cortex in schizophrenia. Neuroreport 2012; 23:1031-1034.
41. Tao R, Li C, Newburn EN, et al. Transcript-specific associations of SLC12A5 (KCC2) in human prefrontal cortex with development, schizophrenia, and affective disorders. J Neurosci 2012; 32:5216-5222.
42. Habl G, Schmitt A, Zink M, et al. Decreased reelin expression in the left prefrontal cortex (BA9) in chronic schizophrenia patients. Neuropsycho-biology 2012; 66:57-62.
43. Perez-Santiago J, Diez-Alarcia R, Callado LF, et al. A combined analysis of microarray gene expression studies of the human prefrontal cortex identifies genes implicated in schizophrenia. J Psychiatr Res 2012; 46:1464-1474.
44. Mistry M, Gillis J, Pavlidis P. Genome-wide expression profiling of schizophrenia using a large combined cohort. Mol Psychiatry 2013; 18:215-225.
45. Cohen OS, McCoy SY, Middleton FA, et al. Transcriptomic analysis of postmortem brain identifies dysregulated splicing events in novel candidate genes for schizophrenia. Schizophr Res 2012; 142:188-199.
46. Kahler AK, Djurovic S, Kulle B, et al. Association analysis of schizophrenia on 18 genes involved in neuronal migration: MDGA1 as a new susceptibility gene. Am J Med Genet B Neuropsychiatr Genet 2008; 147B:1089-1100.
47. Wu JQ, Wang X, Beveridge NJ, et al. Transcriptome sequencing revealed significant alteration of cortical promoter usage and splicing in schizophrenia. PLoS ONE 2012; 7:e36351.
48. Xu B, Ionita-Laza I, Roos JL, et al. De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat Genet 2012; 44:1365-1369.
49. Gilman SR, Chang J, Xu B, et al. Diverse types of genetic variation converge on functional gene networks involved in schizophrenia. Nat Neurosci 2012; 15:1723-1728.
50. Klei L, Sanders SJ, Murtha MT, et al. Common genetic variants, acting additively, are a major source of risk for autism. Mol Autism 2012; 3:9.